Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2007 August;98(4) > Minerva Medica 2007 August;98(4):323-30

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,878


eTOC

 

EDITORIAL  ENDOSCOPIC ULTRASOUND IN 2007


Minerva Medica 2007 August;98(4):323-30

Copyright © 2007 EDIZIONI MINERVA MEDICA

language: English

Endoscopic ultrasound and staging of non-small cell lung cancer

Gill K. R. S., Wallace M. B.

Department of Gastroenterology and Hepatology Mayo Clinic Jacksonville, FL, USA


PDF  


Accurate cancer staging allows the most favorable therapy and prognosis of a neoplastic process, and allows consistency when performing clinical trials for different stages of tumors. In the case of non small-cell lung cancer (NSCLC), the most important parameters for optimal treatment and prognosis are the presence of cancer spread to the lymph nodes within the mediastinum, and to distant organs. Endoscopic ultrasound (EUS) has become a significant tool for the assessment of mediastinal lymph nodes, and in some cases, distant organ metastases because of its minimally invasive access to these sites through a trans-esophageal or trans-gastric approach. The capability of performing fine needle aspiration (FNA) has greatly improved the accuracy and popularity of EUS for lung cancer staging. This review will outline the basic principals of lung cancer staging, EUS-FNA techniques, and role of EUS-FNA in lung cancer staging.

top of page

Publication History

Cite this article as

Corresponding author e-mail